Skip to content
healthcare.dev

24 HR empagliflozin 5 MG / linagliptin 2.5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [Trijardy]

RxNorm concept 2359358, branded drug (sbd). Prescribable name: Trijardy XR 5 MG / 2.5 MG / 1000 MG 24HR Extended Release Oral Tablet.

RxCUI
2359358
Term type
Branded drug (SBD)
Status
Active
Request
curl https://api.healthcare.dev/v1/drugs/rxnorm/2359358 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

Other names

24 HR empagliflozin 5 MG / linagliptin 2.5 MG / metFORMIN hydrochloride 1000 MG Extended Release Oral Tablet [Trijardy]; Trijardy XR (empagliflozin 5 MG / linagliptin 2.5 MG / metFORMIN hydrochloride 1000 MG) 24HR Extended Release Oral Tablet; Trijardy XR (empagliflozin 5 MG / linagliptin 2.5 MG / metformin hydrochloride 1000 MG) 24HR Extended Release Oral Tablet

Related concepts

Linked data

NDCs

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 2359358 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/rxnorm/2359358 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up RxNorm concept 2359358. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.